# OnCo record tagworks-pharmaceuticals (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/tagworks-pharmaceuticals/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "tagworks-pharmaceuticals" ;
  schema:name "Tagworks Pharmaceuticals"@en ;
  schema:alternateName "Tagworks Pharmaceuticals BV"@en ;
  schema:description "Tagworks Pharmaceuticals makes antibody-drug conjugates whose cancer-killing payload is released only when a second, separately injected molecule reaches the tumour. Its first product, TGW101, is in an early trial in advanced solid tumours."@en ;
  schema:url <https://onco.cc/companies/tagworks-pharmaceuticals/>, <https://www.tagworkspharma.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://www.tagworkspharma.com/>, <https://www.tagworkspharma.com/tagworks-fda-clearance-phase1-tgw101-keith-orford-cmo>, <https://www.tagworkspharma.com/tagworks-phase-0-1-clinical-trial-tgw211-her2-radiopharmaceutical>, <https://clinicaltrials.gov/study/NCT06959706> ;
  schema:addressCountry "NL" ;
  onco:sections <https://onco.cc/fronts/adcs/>, <https://onco.cc/fronts/radiopharma/> ;
  onco:technologies <https://onco.cc/technologies/adc/>, <https://onco.cc/technologies/radioimmunotherapy/> ;
  onco:targets <https://onco.cc/targets/her2/> .